[{"address1": "7-11 boulevard Haussmann", "city": "Paris", "zip": "75009", "country": "France", "phone": "33 1 53 83 09 63", "website": "https://www.abivax.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ABIVAX Soci\u00e9t\u00e9 Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.", "fullTimeEmployees": 67, "companyOfficers": [{"maxAge": 1, "name": "Mr. Marc M. P. de Garidel M.B.A.", "age": 67, "title": "Chief Executive Officer", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 741584, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Didier  Blondel", "age": 61, "title": "EVP, CFO & Board Secretary", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Didier  Scherrer Ph.D.", "age": 55, "title": "Chief Scientific Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Patrick  Malloy", "title": "Senior Vice President of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ida  Hatoum", "age": 50, "title": "Chief People & Compliance Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Pierre  Courteille M.B.A.", "age": 57, "title": "Chief Business Officer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jerome  Denis Ph.D.", "title": "Executive Vice President of Process Development & Manufacturing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Hema  Keshava", "title": "Senior Vice President of Finance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Chris  Rabbat Ph.D.", "title": "VP & Global Head of Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Kevin  Shan Ph.D.", "title": "VP & Global Head of Biometrics", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 123.63, "open": 122.32, "dayLow": 122.0, "dayHigh": 125.86, "regularMarketPreviousClose": 123.63, "regularMarketOpen": 122.32, "regularMarketDayLow": 122.0, "regularMarketDayHigh": 125.86, "payoutRatio": 0.0, "beta": -0.25, "forwardPE": -37.27489, "volume": 746493, "regularMarketVolume": 746493, "averageVolume": 1714233, "averageVolume10days": 2283710, "averageDailyVolume10Day": 2283710, "bid": 121.74, "ask": 122.33, "bidSize": 3, "askSize": 1, "marketCap": 9579598848, "fiftyTwoWeekLow": 4.77, "fiftyTwoWeekHigh": 148.83, "allTimeHigh": 148.83, "allTimeLow": 4.77, "priceToSalesTrailing12Months": 1803.7279, "fiftyDayAverage": 120.998, "twoHundredDayAverage": 64.89396, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 8988893184, "profitMargins": 0.0, "floatShares": 51786570, "sharesOutstanding": 78444148, "sharesShort": 2908643, "sharesShortPriorMonth": 2296266, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.0373, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.74538004, "shortRatio": 1.54, "shortPercentOfFloat": 0.044299997, "impliedSharesOutstanding": 78444148, "bookValue": 7.7209396, "priceToBook": 15.816728, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -293520000, "trailingEps": -5.21, "forwardEps": -3.2762, "enterpriseToRevenue": 1692.505, "enterpriseToEbitda": -41.242, "52WeekChange": 19.267214, "SandP52WeekChange": 0.14987159, "quoteType": "EQUITY", "currentPrice": 122.12, "targetHighPrice": 176.0, "targetLowPrice": 131.0, "targetMeanPrice": 152.7, "targetMedianPrice": 147.5, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 10, "totalCash": 589702976, "totalCashPerShare": 7.577, "ebitda": -217952992, "totalDebt": 73988000, "quickRatio": 7.737, "currentRatio": 7.863, "totalRevenue": 5311000, "debtToEquity": 14.472, "revenuePerShare": 0.081, "returnOnAssets": -0.31671, "returnOnEquity": -1.06382, "grossProfits": 5311000, "freeCashflow": -180175376, "operatingCashflow": -171415008, "revenueGrowth": -0.527, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -126.30829, "financialCurrency": "EUR", "symbol": "ABVX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketPrice": 122.99, "postMarketChange": 0.8699951, "regularMarketChange": -1.50999, "regularMarketDayRange": "122.0 - 125.86", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1714233, "fiftyTwoWeekLowChange": 117.350006, "fiftyTwoWeekLowChangePercent": 24.601679, "fiftyTwoWeekRange": "4.77 - 148.83", "fiftyTwoWeekHighChange": -26.71, "fiftyTwoWeekHighChangePercent": -0.1794665, "fiftyTwoWeekChangePercent": 1926.7214, "earningsTimestamp": 1774299600, "earningsTimestampStart": 1774299600, "earningsTimestampEnd": 1774299600, "earningsCallTimestampStart": 1712579400, "earningsCallTimestampEnd": 1712579400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -5.21, "epsForward": -3.2762, "epsCurrentYear": -4.21833, "priceEpsCurrentYear": -28.949846, "fiftyDayAverageChange": 1.1220016, "fiftyDayAverageChangePercent": 0.009272894, "twoHundredDayAverageChange": 57.226044, "twoHundredDayAverageChangePercent": 0.8818393, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-10-20", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1697808600000, "postMarketChangePercent": 0.71241003, "shortName": "Abivax SA", "longName": "ABIVAX Soci\u00e9t\u00e9 Anonyme", "corporateActions": [], "postMarketTime": 1769216184, "regularMarketTime": 1769202001, "exchange": "NGM", "messageBoardId": "finmb_256839883", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.22138, "regularMarketPrice": 122.12, "trailingPegRatio": null, "__fetch_time": "2026-01-24"}]